BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 2086120)

  • 1. [The clinical significance of flow cytometric DNA measurement of paraffin specimen in bladder tumor].
    Wang Z
    Zhonghua Wai Ke Za Zhi; 1990 Aug; 28(8):505-8, 512. PubMed ID: 2086120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors.
    Miao T; Wang Z; Sang N; Xiong R; Cao S
    Eur Urol; 1992; 21(2):98-102. PubMed ID: 1499623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Oncogene ras P 21 expression and DNA ploidy in human bladder tumor].
    Wang Z
    Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):245-8. PubMed ID: 1806342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA content and proliferation activity in superficial transitional cell carcinoma of the bladder.
    Pantazopoulos D; Ioakim-Liossi A; Karakitsos P; Aroni K; Kakoliris S; Kanavaros P; Kyrkou KA
    Anticancer Res; 1997; 17(1B):781-6. PubMed ID: 9066620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic significance of DNA content in transitional cell carcinoma of the urinary bladder].
    Sun X
    Zhonghua Zhong Liu Za Zhi; 1992 Jan; 14(1):24-6. PubMed ID: 1396041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on nuclear DNA content in bladder cancers using flow cytometry].
    Toyota K
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):45-53. PubMed ID: 8727374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxyribonucleic acid ploidy and the clinical pattern of grade 2 superficial bladder cancer.
    Neulander E; Kaneti J; Chaimovitz C; Sion-Vardy N; Douvdevani A
    J Urol; 1997 Apr; 157(4):1254-8; discussion 1258-9. PubMed ID: 9120914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flow cytometric measurements of deoxyribonucleic acid ploidy and proliferative activity for evaluating malignant potential of human bladder cancers.
    Miyakawa A; Tachibana M; Tazaki H
    Cancer Detect Prev; 1995; 19(2):165-72. PubMed ID: 7750104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of proliferative activity estimated by bromodeoxyuridine labeling index in determining predictive factors of recurrence in superficial intermediately malignant bladder tumors.
    Tachibana M; Miyakawa A; Nakamura K; Baba S; Murai M; Tazaki H
    J Urol; 1996 Jul; 156(1):63-9. PubMed ID: 8648839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometry and prognostic implications in patients with solid tumors.
    Williams NN; Daly JM
    Surg Gynecol Obstet; 1990 Sep; 171(3):257-66. PubMed ID: 2201096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of ploidy level in bladder tumors and selected site specimens by flow cytometry.
    Jakobsen A; Mommsen S; Olsen S
    Cytometry; 1983 Sep; 4(2):170-3. PubMed ID: 6628139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric DNA-ploidy as a prognostic indicator in oral squamous cell carcinoma.
    Wang XL; Chen RM; Wang ZS; Chen WL; Zuo LF
    Chin Med J (Engl); 1990 Jul; 103(7):572-5. PubMed ID: 2119974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Flow cytometric analysis in non-small-cell bronchial carcinoma and its prognostic significance].
    Liewald F; Sunder-Plassmann L; Valet G; Wulf G; Weiss M; Schildberg FW
    Chirurg; 1992 Mar; 63(3):205-10. PubMed ID: 1313755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of transitional cell bladder carcinoma. With special reference to ABH blood group isoantigen expression and DNA analysis.
    Malmström PU
    Scand J Urol Nephrol Suppl; 1988; 112():1-55. PubMed ID: 3068792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The DNA content of bladder carcinoma in relation to pathologic grading, staging and prognosis: a flow cytometric study].
    Xue J
    Zhonghua Wai Ke Za Zhi; 1989 Nov; 27(11):650-3, 700. PubMed ID: 2632194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric DNA/cytokeratin analysis of bladder lavage: methodical aspects and clinical implications.
    Liedl T
    Urol Int; 1995; 54(1):22-47. PubMed ID: 7770998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of static cytometry in transitional cell carcinoma of the bladder: recurrence rate and survival in a group of patients at 10 years follow-up.
    Cai T; Margallo E; Nesi G; Giubilei G; Rizzo M; Bartoletti R
    Oncol Rep; 2006 Jan; 15(1):213-9. PubMed ID: 16328058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contribution of cell cycle and DNA content study by flow cytometry in the prognosis of superficial bladder cancer: Tunisian experience].
    Bounemra-Benghanem A; Amri MA; Rammeh-Rommani S; Chebil M; Zermani R; Ben Jilani S; Jenhani F
    Ann Biol Clin (Paris); 2007; 65(1):41-9. PubMed ID: 17264038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of head and neck carcinoma DNA index and S-fraction from paraffin-embedded sections: comparison with malignancy grading.
    Johnson TS; Williamson KD; Cramer MM; Peters LJ
    Cytometry; 1985 Sep; 6(5):461-70. PubMed ID: 4042786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.